argenx SE (ARGX)
argenx SE (ARGX) is a healthcare company (biotechnology) based in the Netherlands. The share price is $949.10, down 0.20% on the day, which values the company at $59.68B. Price as of 17 Nov 2026, 18:23 UTC, from Yahoo Finance.
Key facts
- Share price
- $949.10−0.20% today
- Market value
- $59.68B
- P/E ratio
- 32.9×last 12 months
- Forward P/E
- 28.5×
- Funk Score
- 80/100
- Against its own history
- About its usual priceusual price $971.85
- 200-week average
- $605.3757% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
argenx SE in more detail
ARGX trades at 32.9× its last twelve months' earnings, 28.5× next year's expected earnings, 10.1× sales. Measured against its own history, the price is 2% below what its usual multiples would imply ($971.85) — about its usual price. It sits 57% above its 200-week average of $605.37.
Its Funk Score is 80 out of 100 (financial strength 9.1, profitability 7.9, growth 10.0, value 4.9, each out of 10).
In its favour: Altman Z in the safe zone; Operating margin is expanding. Worth checking: Beneish M-score flags the accounts; Share count keeps rising.
2 of the superinvestors tracked here hold ARGX, including Frank Sands (1.0% of the portfolio), Ron Baron (0.2% of the portfolio).
Superinvestors holding ARGX
2 of the investors tracked here report a position in their latest 13F filing.
- Frank Sands Sands Capital Management1.05% of portfolio · $259.1M · trimmed · Q3 2026
- Ron Baron Baron Capital (BAMCO)0.21% of portfolio · $125.6M · trimmed · Q3 2026
Health Care companies of similar size
- Takeda PharmaceuticalTAK
- CencoraCOR
- Boston ScientificBSX
- Cardinal HealthCAH
- Edwards LifesciencesEW
- Becton, DickinsonBDX
- IDEXX LaboratoriesIDXX
- MedlineMDLN
- HumanaHUM
- Agilent TechnologiesA
- Teva Pharmaceutical IndustriesTEVA
- BeOne MedicinesONC
Side by side:ARGX vs EW (argenx SE vs Edwards Lifesciences)ARGX vs BDX (argenx SE vs Becton, Dickinson)ARGX vs CAH (argenx SE vs Cardinal Health)ARGX vs BSX (argenx SE vs Boston Scientific)ARGX vs IDXX (argenx SE vs IDEXX Laboratories)
All health care companies by market valueLargest companies in BelgiumAll stocks A–Z
argenx SE (ARGX): questions and answers
What is ARGX's P/E ratio?
argenx SE trades at 32.9× its last twelve months' earnings and 28.5× next year's expected earnings.
What is ARGX's PEG ratio?
argenx SE's PEG ratio is 1.30 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is argenx SE's market cap?
argenx SE is valued at $59.68B at a share price of $949.10.
Is ARGX overvalued or undervalued?
Against its own history, ARGX is about its usual price: the price is 2% below the $971.85 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is ARGX above its 200-week moving average?
Yes. ARGX is 56.8% above its 200-week average of $605.37. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is argenx SE growing?
Over the last three fiscal years argenx SE's revenue grew 116.2% a year.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “argenx SE (ARGX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ARGX
Underlying data: Yahoo Finance; company filings with the SEC.